Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of Medicare and Medicaid beneficiaries. In a New York Times op-ed, Fetterman appealed to President Trump and Health and Human Services Secretary Robert F. Kennedy…
Source link
2025-04-09
